Check-Cap Ltd. (NASDAQ:CHEK – Get Rating) was the recipient of a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 1,250,000 shares, a decrease of 8.1% from the August 15th total of 1,360,000 shares. Based on an average daily trading volume, of 509,300 shares, the short-interest ratio is presently 2.5 days.
Check-Cap Price Performance
Shares of NASDAQ CHEK opened at $0.31 on Tuesday. Check-Cap has a one year low of $0.29 and a one year high of $1.31. The business’s fifty day moving average price is $0.34 and its 200-day moving average price is $0.35. The stock has a market capitalization of $29.48 million, a PE ratio of -1.53 and a beta of 0.31.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Check-Cap stock. Virtu Financial LLC grew its position in shares of Check-Cap Ltd. (NASDAQ:CHEK – Get Rating) by 363.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 224,696 shares of the medical research company’s stock after buying an additional 176,207 shares during the period. Virtu Financial LLC owned 0.23% of Check-Cap worth $69,000 at the end of the most recent reporting period. 1.33% of the stock is currently owned by hedge funds and other institutional investors.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
- Get a free copy of the StockNews.com research report on Check-Cap (CHEK)
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.